Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron Reports Fourth Quarter and Full Year 2015 Financial and Operating Results

02/09/16

TARRYTOWN, N.Y., Feb. 9, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced financial results for the fourth quarter and full year 2015 and provided an update on development programs. Financial Highlights ...

Read more

Upcoming Events

Regeneron Pharmaceuticals Q4 2015 Earnings Conference Call

02/09/16 at 8:30 AM ET

View Event

Leerink Partners 5th Annual Global Healthcare Conference

02/11/16 at 8:30 AM

View Event




Close
Form content here please :)